While both treatments offer benefits, GLP-1 receptor agonists generally have fewer side effects that patients find easier to tolerate, which leads to better adherence
Curious about how they can do this
A study published in the journal Obesity found that participants taking 300 mg/day of Wellbutrin SR lost about 7 percent of their body weight over 24 weeks, while those on 400 mg/day lost up to 10 percent
[DOI] [PubMed] [Google Scholar] [23].Kraus JP, Janosik M, Kozich V, Mandell R, Shih V, Sperandeo MP, et al
This complication is entirely preventable through consistent site rotation, so your body maintains steady therapeutic levels throughout your treatment
So you draw up 20 units on your U-100 syringe to deliver a 0.5mg dose from a 2.5mg/mL vial